Relevant bibliographies by topics / Anti-ulcer agent

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Anti-ulcer agent'

Author: Grafiati
Published: 4 June 2021
Last updated: 16 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anti-ulcer agent.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anti-ulcer agent"

1

Isobe, Yoshihiko, Yoichi Kiuchi, Haruko Kijita, Makoto Muramatsu, and Susuau Otoao. "Anti-ulcer and anti-secretory effects of SU-840, a novel anti-ulcer agent." Japanese Journal of Pharmacology 64 (1994): 282. http://dx.doi.org/10.1016/s0021-5198(19)50760-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kondo, Isamu, and Masashl Yamaguchi. "Morphological changes of Helicobacter pylori caused in vitro by cytoprotective anti-ulcer drug, Sofalcone." Proceedings, annual meeting, Electron Microscopy Society of America 48, no. 3 (1990): 620–21. http://dx.doi.org/10.1017/s0424820100160650.

Full text
Abstract:
Since Helicobacter pylori has recently been regarded as a possible causative agent of a chronic gastritis and a peptic ulcer disease, the susceptibilities of this organism to anti-ulcer agents or antibiotics have attracted much interest of not only clinical docters but also medicobiologists.We have reported that Sofalcone, a cytoprotective anti-ulcer drug, has anti-bacterial and bactericidal activity as well as TDS (tripotassium dicitrats bithmuthate) and Clarithromycin (a derivative of erythromycin), but the other anti-ulcer drugs Including anti-acid or H2 receptor antagonists such as cimetid
APA, Harvard, Vancouver, ISO, and other styles
3

Dedieu-Chaufour, C., F. Hertz, F. Caussade, and A. Cloarec. "UP 5145-52: A mew anti-ulcer and antisecretory agent." European Journal of Pharmacology 183, no. 2 (1990): 298–99. http://dx.doi.org/10.1016/0014-2999(90)93154-i.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

TANAKA, Hisashi, and Shun-ichi NAITO. "Pharmacokinetic and pharmacological studies on cetraxate, an anti-ulcer agent." Folia Pharmacologica Japonica 85, no. 5 (1985): 357–66. http://dx.doi.org/10.1254/fpj.85.357.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zeniya, Akira, Michiro Otaka, Toshiyuki Kuwabara, Shusel Fujimori, Setsuya Otani, and Osamu Masamune. "Anti-Ulcer effect of FK 506, immunosuppressive agent, in rats." Journal of Gastroenterology 29, no. 3 (1994): 383–84. http://dx.doi.org/10.1007/bf02358382.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Matsumoto, Tsuyoshi, Kenichi Sakurai, Asami Tanaka, et al. "The anti-ulcer agent, irsogladine, increases insulin secretion by MIN6 cells." European Journal of Pharmacology 685, no. 1-3 (2012): 213–17. http://dx.doi.org/10.1016/j.ejphar.2012.04.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jhuma, Azima Aktar, Md Moynul Haque, Jamil Ahmed, Shantanu Das, Tarun Kanti Paul, and Md Mahbubur Rahman. "Microbial Agents Causing Infective Corneal Ulcer and their Anti-microbial Susceptibility pattern." Bangladesh Medical Journal 47, no. 2 (2019): 1–6. http://dx.doi.org/10.3329/bmj.v47i2.43502.

Full text
Abstract:
This study was designed to identify the microbial agents causing infective corneal ulcer and to carry out the antimicrobial susceptibility patterns of isolated bacteria causing infective corneal ulcer. Out of 80 samples, 67 (83.75%) cases were positive by microscopy and culture. This study showed pure fungal growth in 39 (48.75%) cases, pure bacterial growth in 8 (10%) cases, mixed microbial growth (both fungi and bacteria) in 20 (25%) cases and no growth was observed in 13 (16.25%) cases. Among the fungal isolates, Aspergillus species was the leading agent detected in 37(46.3%) cases followed
APA, Harvard, Vancouver, ISO, and other styles
8

Shigeru, Murakami, Muramatsu Makoto, Aihara Hironaka, and Otomo Susumu. "Inhibition of gastric H+,K+-ATPase by the anti-ulcer agent, sofalcone." Biochemical Pharmacology 42, no. 7 (1991): 1447–51. http://dx.doi.org/10.1016/0006-2952(91)90458-h.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hoshina, Kenji, Noboru Yamazaki, Hiroaki Mitsuhashi, Toru Takeshita, and Tatsuyuki Naruchi. "A novel anti-ulcer agent, TEI-5103, promotes the gastric mucosal barrier." Japanese Journal of Pharmacology 43 (1987): 232. http://dx.doi.org/10.1016/s0021-5198(19)58499-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kuroki, Akiko Mera, Takashi Kitaoka, Yoko Matsuo, and Tsugio Amemiya. "Inhibition of Experimental Choroidal Neovascularization by Irsogladine, an Anti-Gastric Ulcer Agent." Ophthalmic Research 35, no. 3 (2003): 137–42. http://dx.doi.org/10.1159/000070048.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Anti-ulcer agent"

1

Copeman, Matthew B. "Gastric mucosal protection by anti-ulcer agents." Thesis, University of Newcastle Upon Tyne, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.384877.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chak, Man-lee Charlotta. "A retrospective study on the effectiveness of anti-ulcer drugs in the prevention of nonsteroidal inflammatory drugs (NSAID)-induced gastrointestinal effects." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31971453.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sagar, Mohamed. "The importance of the CYP2C19 polymorphism for disposition and effects of omeprazole treatment /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3624-2/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chak, Man-lee Charlotta, and 翟敏莉. "A retrospective study on the effectiveness of anti-ulcer drugs in the prevention of nonsteroidal inflammatory drugs (NSAID)-inducedgastrointestinal effects." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B31971453.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mantzaris, Debbie 1974. "Investigation of the mechanisms involved in delayed ulcer healing by nonsteroidal anti-inflammatory drugs (NSAIDs)." Monash University, Dept. of Surgery, 2001. http://arrow.monash.edu.au/hdl/1959.1/8095.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lai, Kam-chuen. "Management of peptic ulcer bleeding the significance of Helicobacter pylori and non-steroidal anti-inflammatory drugs /." Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/B31997156.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wheeldon, Thục-Uyên. "Management of Helicobacter pylori infection in Vietnam /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7349-876-9/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lai, Kam-chuen, and 黎錦泉. "Management of peptic ulcer bleeding: the significance of Helicobacter pylori and non-steroidal anti-inflammatory drugs." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B31997156.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hoang, Thi Thu Ha. "Serodiagnosis and seroprevalence of Helicobacter pylori infection in Vietnam /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-918-1/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jorge, Michelle Pedroza 1981. "Atividade cicatrizante do extrato bruto de Arrabidaea chica (Humb. & Bonpl.) verlot." [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/309829.

Full text
Abstract:
Orientadores: João Ernesto de Carvalho, Mary Ann Foglio, Lucia Tasca Gois Ruiz<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas<br>Made available in DSpace on 2018-08-11T14:23:42Z (GMT). No. of bitstreams: 1 Jorge_MichellePedroza_M.pdf: 2723510 bytes, checksum: d0521f341cbca8308beb772206b9dd69 (MD5) Previous issue date: 2008<br>Resumo: As folhas de Arrabidaea chica (Humb. & Bonpl.) Verlot (Bignoniaceae), popularmente conhecida como Crajiru, são utilizadas na medicina popular como cicatrizante, antiinflamatória e no tratamento de cólicas intestinais
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Anti-ulcer agent"

1

Clinch, David. Peptic ulcer and its drug causation: The role of non-steroidal anti-inflammatory drugs. Croom Helm, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Halpern, Georges M. Ulcer free!: Nature's safe & effective remedy for ulcers. Square One Publishers, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Toner, Shannon. Anti-ulcer agent use in a teaching hospital setting. 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

1944-, Szabo Sandor, and Mózsik Gy, eds. New pharmacology of ulcerdisease. Elsevier, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

New pharmacology of ulcer disease: Experimental and new therapeutic approaches. Elsevier, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Halpern, Georges M. Zinc-Carnosine: Nature's Safe and Effective Remedy for Ulcers. Square One Publishers, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1947-, Swabb Edward A., and Szabo Sandor 1944-, eds. Ulcer disease: Investigation and basis for therapy. M. Dekker, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Peptic Ulcer & Its Drug Causation: The Role of Non-Steroidal Anti-Inflammatory Drugs. Routledge & Kegan Paul Books Ltd, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

A, Garner, Whittle B. J. R, and Biological Council Symposium on Drug Action (38th : 1988 : Royal Institution, London), eds. Advances in drug therapy of gastrointestinal ulceration. Wiley, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Frost & Sullivan., ed. European anti-peptic ulcer pharmaceuticals markets: Booming proton pump inhibitor sector leads dramatic market growth. Frost & Sullivan, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Anti-ulcer agent"

1

Sung, Joseph. "Peptic ulcer disease." In Oxford Textbook of Medicine, edited by Jack Satsangi. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0295.

Full text
Abstract:
Helicobacter pylori infection, use of nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin, and smoking are the most important causes of peptic ulcer disease. Peptic ulcer disease is characterized by a history of waxing and waning symptoms of localized, dull, aching pain in the upper abdomen. Bleeding is the most common complication; free perforation of the stomach or duodenum into the peritoneal cavity is uncommon but serious. The diagnosis of peptic ulcer disease is made by endoscopy, which offers an opportunity for biopsy of gastric ulcers (which may be malignant) and reveals important prognostic indicators in patients with bleeding ulcers. A single daily dose of a proton pump inhibitor gives quick relief of symptoms and effective healing of peptic ulcers in 4 to 6 weeks. The management of patients with upper gastrointestinal haemorrhage requires a multidisciplinary medical and surgical approach. Early risk stratification based on clinical and endoscopic criteria allows delivery of appropriate care, with endoscopic intervention now widely accepted as the first line of therapy. This should be followed by administration of a high dose of an intravenous proton pump inhibitor to further reduce recurrent bleeding. Treatment of H. pylori is a cure for peptic ulcer disease in most patients. This usually requires at least two antimicrobial agents, with the most popular triple therapy combining a proton pump inhibitor with any two of amoxicillin, metronidazole, and clarithromycin for 7 to 14 days. Eradication of H. pylori infection, avoidance of high-dose NSAIDs or aspirin, and the maintenance use of proton pump inhibitors in high-risk individuals are the best ways to prevent recurrence of ulcer and ulcer complications.
APA, Harvard, Vancouver, ISO, and other styles
2

Maria Dascalu, Ana, Dragos Serban, Nikolaos Papanas, et al. "Microvascular Complications of Diabetes Mellitus: Focus on Diabetic Retinopathy (DR) and Diabetic Foot Ulcer (DFU)." In Type 2 Diabetes [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.96548.

Full text
Abstract:
Diabetic retinopathy and diabetic foot ulcer are the most frequent, but also the most disabling complications of diabetes mellitus, with a sinister impact on patients’ quality of life. Microvascular changes related to the deleterious effect of chronic hyperglycemia play an important role in the pathophysiology of both clinical entities by multiple molecular pathways. Vision-threating diabetic retinopathy may be treated by laser photocoagulation, anti-vascular endothelial growth factor (VEGF) agents and vitreoretinal surgery. Diabetic foot lesions are best treated by revascularization if needed, off-loading, infection control and therapeutic adjuncts (e.g. special dressings). Treatment should ideally be offered by a multidisciplinary expert team. Prevention and early detection, along with adequate control of glucose, lipids and arterial hypertension are of paramount importance to avoid and mitigate these fearful complications.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Anti-ulcer agent"

1

Sriepindonnta, Priscilla Maiselina, Fatimah Nur Fitriani, Savannah Quila Thirza та ін. "The potential effects of Centella asiatica ethanolic extracts as an anti-inflammatory agent through decreasing TNF-α expression in indomethacin-induced gastric ulcer model rats". У INTERNATIONAL CONFERENCE ON LIFE SCIENCES AND TECHNOLOGY (ICoLiST 2020). AIP Publishing, 2021. http://dx.doi.org/10.1063/5.0053018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Anti-ulcer agent' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography